We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDH
3651
DELISTED
MDH Acquisition Corp.
MDH
-1,106,042
Closed -$10.9M
AKIC
3652
DELISTED
Sports Ventures Acquisition Corp. Class A Ordinary Shares
AKIC
-1,022,343
Closed -$10.2M
AKICW
3653
CALL
DELISTED
Sports Ventures Acquisition Corp. Warrant
AKICW
-256,661
Closed -$2.56M
ISAA
3654
DELISTED
Iron Spark I Inc. Class A Common Stock
ISAA
-750,000
Closed -$7.42M
LFG
3655
DELISTED
Archaea Energy Inc.
LFG
-856,307
Closed -$15.4M
FTVIW
3656
CALL
DELISTED
FinTech Acquisition Corp. VI Warrants
FTVIW
-62,496
Closed -$623K
FTVI
3657
DELISTED
FinTech Acquisition Corp. VI Class A Common Stock
FTVI
-337,913
Closed -$3.36M
GACQ
3658
DELISTED
Global Consumer Acquisition Corp. Common Stock
GACQ
-351,305
Closed -$3.58M
SHCA
3659
DELISTED
Spindletop Health Acquisition Corp. Class A Common Stock
SHCA
-853,199
Closed -$8.59M
SHCAW
3660
CALL
DELISTED
Spindletop Health Acquisition Corp. Warrant
SHCAW
-175,000
Closed -$1.76M
HUGS
3661
DELISTED
USHG Acquisition Corp.
HUGS
-938,470
Closed -$9.24M
OMEG
3662
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
-270,719
Closed -$2.69M
GACQW
3663
CALL
DELISTED
Global Consumer Acquisition Corp. Warrant
GACQW
-155,516
Closed -$1.68M
SPTK
3664
DELISTED
SportsTek Acquisition Corp. Class A Common Stock
SPTK
-721,149
Closed -$7.1M
SPTKW
3665
CALL
DELISTED
SportsTek Acquisition Corp. Warrant
SPTKW
-166,658
Closed -$1.66M
GIWWW
3666
CALL
DELISTED
GigInternational1, Inc. Warrant
GIWWW
-331,238
Closed -$3.39M
MONCW
3667
CALL
DELISTED
Monument Circle Acquisition Corp. Warrant
MONCW
-605,646
Closed -$5.99M
MON
3668
DELISTED
Monument Circle Acquisition Corp. Class A Common Stock
MON
-1,135,936
Closed -$11.2M
SGHC.WS
3669
CALL
DELISTED
Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share
SGHC.WS
-360,000
Closed -$1.47M
AFAQ
3670
DELISTED
AF Acquisition Corp
AFAQ
-991,358
Closed -$9.71M
AFAQW
3671
CALL
DELISTED
AF Acquisition Corp Warrants
AFAQW
-249,997
Closed -$2.48M
HCARW
3672
CALL
DELISTED
Healthcare Services Acquisition Corporation Warrant
HCARW
-349,450
Closed -$3.47M
HCAR
3673
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
-1,283,186
Closed -$12.8M
PSAG
3674
DELISTED
Property Solutions Acquisition Corporation II Class A Common Stock
PSAG
-1,223,767
Closed -$12M
ABMD
3675
DELISTED
Abiomed Inc
ABMD
-3,803
Closed -$934K

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.